|
G |
Ache |
acetylcholinesterase |
decreases activity increases phosphorylation multiple interactions increases acylation decreases response to substance decreases expression |
ISO EXP |
Dichlorvos metabolite results in decreased activity of ACHE protein; Dichlorvos results in decreased activity of ACHE protein Dichlorvos results in increased phosphorylation of ACHE protein [Carbaryl co-treated with Dichlorvos] results in decreased activity of ACHE protein; [crotoxyphos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Dichlorvos results in increased phosphorylation of ACHE protein] inhibits the reaction [thioflavin T binds to ACHE protein]; [malaoxon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Malathion co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Mevinphos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Paraoxon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Parathion co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Phosphamidon co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Physostigmine co-treated with Dichlorvos] results in decreased activity of ACHE protein; [Trichlorfon co-treated with Dichlorvos] results in decreased activity of ACHE protein; asoxime chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Dichlorvos promotes the reaction [Chlorpromazine results in decreased activity of ACHE protein]; HLo 7 inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Tiapamil Hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein] [bacoside A co-treated with Plant Preparations] inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; Atropine promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; coumarin inhibits the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; Dichlorvos binds to and results in decreased activity of ACHE protein; Dichlorvos promotes the reaction [malaoxon results in decreased activity of ACHE protein]; Gallamine Triethiodide affects the reaction [Dichlorvos results in increased acylation of ACHE protein]; Gallamine Triethiodide promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; Propidium promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; Tubocurarine promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein] ACHE protein results in decreased susceptibility to Dichlorvos 1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; [Dichlorvos co-treated with Monocrotophos] results in increased activity of ACHE protein; [Monocrotophos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [pralidoxime co-treated with Atropine] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; [sodium arsenite co-treated with Dichlorvos co-treated with Monocrotophos] results in decreased activity of ACHE protein; [sodium arsenite co-treated with Dichlorvos] results in decreased activity of ACHE protein; Dichlorvos inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [[Atropine co-treated with Curcumin] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein] Dichlorvos results in decreased expression of ACHE mRNA; Dichlorvos results in decreased expression of ACHE protein |
CTD |
PMID:119426 PMID:235931 PMID:473212 PMID:475593 PMID:597376 PMID:1258061 PMID:1494302 PMID:1609424 PMID:1855619 PMID:2086312 PMID:2537085 PMID:3247000 PMID:3945941 PMID:4859365 PMID:6933967 PMID:7150809 PMID:7218377 PMID:7234437 PMID:7713347 PMID:8231460 PMID:8359835 PMID:8579882 PMID:8783813 PMID:9268605 PMID:9515941 PMID:9586870 PMID:10421444 PMID:10975133 PMID:12018594 PMID:14631503 PMID:15033007 PMID:15679473 PMID:15793557 PMID:15979224 PMID:16036766 PMID:16193528 PMID:16598855 PMID:16978018 PMID:17188317 PMID:17722737 PMID:18070496 PMID:18423506 PMID:19100812 PMID:19631781 PMID:20026515 PMID:20396698 PMID:20412842 PMID:21251949 PMID:21349312 PMID:21673941 PMID:21767560 PMID:22209767 PMID:22783142 PMID:23220589 PMID:25082528 PMID:25895260 PMID:26814074 PMID:27899289 PMID:30625376 PMID:33517499 PMID:33574433 PMID:33720374 PMID:33844597 PMID:34078836 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization multiple interactions |
EXP |
Dichlorvos affects the localization of AIFM1 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos affects the localization of AIFM1 protein] |
CTD |
PMID:24231740 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
Dichlorvos results in increased expression of AKR7A3 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Dichlorvos binds to ALB protein |
CTD |
PMID:15525694 PMID:17188226 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
Dichlorvos results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Anxa2 |
annexin A2 |
increases expression |
EXP |
Dichlorvos results in increased expression of ANXA2 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Apeh |
acylaminoacyl-peptide hydrolase |
decreases activity |
ISO EXP |
Dichlorvos results in decreased activity of APEH protein |
CTD |
PMID:15888665 PMID:19379766 |
|
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
|
|
G |
App |
amyloid beta precursor protein |
increases secretion |
ISO EXP |
Dichlorvos results in increased secretion of APP protein alternative form Dichlorvos results in increased secretion of APP protein modified form |
CTD |
PMID:7605915 PMID:8624119 PMID:11526466 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Dichlorvos promotes the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:17219378 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions increases expression |
EXP |
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of ATM mRNA] Dichlorvos results in increased expression of ATM mRNA; Dichlorvos results in increased expression of ATM protein |
CTD |
PMID:24369695 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
Dichlorvos results in increased expression of BAX protein |
CTD |
PMID:22817663 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions decreases activity decreases expression |
ISO EXP |
[Dichlorvos results in decreased activity of BCHE protein] which results in increased susceptibility to Succinylcholine; Dichlorvos binds to and results in decreased activity of BCHE protein; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; Tiapamil Hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein] [bacoside A co-treated with Plant Preparations] inhibits the reaction [Dichlorvos results in decreased expression of BCHE protein]; Dichlorvos binds to and results in decreased activity of BCHE protein diacetylmonoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; Magnesium Sulfate promotes the reaction [Dichlorvos results in decreased activity of BCHE protein] |
CTD |
PMID:235931 PMID:423703 PMID:1276991 PMID:4631366 PMID:7150809 PMID:12190811 PMID:12828128 PMID:16036766 PMID:16193528 PMID:16598855 PMID:17698511 PMID:19504058 PMID:20229498 PMID:20395308 PMID:21673941 PMID:21767560 PMID:22209767 PMID:27899289 PMID:33517499 More...
|
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
Dichlorvos results in increased expression of BTG2 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Casp1 |
caspase 1 |
increases expression |
EXP |
Dichlorvos results in increased expression of CASP1 mRNA |
CTD |
PMID:23053939 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions decreases expression increases expression increases cleavage |
ISO EXP |
Dichlorvos results in increased activity of CASP3 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; Dichlorvos results in increased cleavage of and results in increased activity of CASP3 protein; mitoquinone inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased cleavage of CASP3 protein] Dichlorvos results in decreased expression of CASP3 mRNA Dichlorvos results in increased expression of CASP3 mRNA |
CTD |
PMID:16973328 PMID:17681413 PMID:17850875 PMID:19815060 PMID:21784090 PMID:22817663 PMID:24369695 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
EXP |
[Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] |
CTD |
PMID:16973328 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity increases activity |
EXP ISO |
[Hexachlorocyclohexane co-treated with Dichlorvos co-treated with Plant Extracts] results in decreased activity of CAT protein; [Hexachlorocyclohexane co-treated with Dichlorvos] results in decreased activity of CAT protein; [Phorate co-treated with acephate co-treated with Dichlorvos co-treated with Dimethoate] results in decreased activity of CAT protein; Acetylcysteine inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; coenzyme Q10 inhibits the reaction [Dichlorvos results in decreased activity of CAT protein] Dichlorvos results in increased activity of CAT protein PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of CAT protein] |
CTD |
PMID:1587340 PMID:20302853 PMID:22034174 PMID:22224058 PMID:22751200 PMID:25891459 PMID:26814074 PMID:27180203 PMID:29143438 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression multiple interactions |
EXP |
Dichlorvos results in increased expression of CDC25A mRNA; Dichlorvos results in increased expression of CDC25A protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDC25A mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDC25A protein] |
CTD |
PMID:24369695 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP |
Dichlorvos results in increased expression of CDKN1A mRNA; Dichlorvos results in increased expression of CDKN1A protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDKN1A mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CDKN1A protein] |
CTD |
PMID:21813463 PMID:24369695 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ces2h |
carboxylesterase 2H |
increases expression |
EXP |
Dichlorvos results in increased expression of CES2 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Chat |
choline O-acetyltransferase |
increases activity |
EXP |
Dichlorvos results in increased activity of CHAT protein |
CTD |
PMID:17722737 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases expression |
EXP |
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CHEK2 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of CHEK2 protein] Dichlorvos results in increased expression of CHEK2 mRNA; Dichlorvos results in increased expression of CHEK2 protein |
CTD |
PMID:24369695 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
decreases expression |
EXP |
Dichlorvos results in decreased expression of CHRM1 protein |
CTD |
PMID:19100812 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
decreases expression |
EXP |
Dichlorvos results in decreased expression of CHRM2 protein |
CTD |
PMID:19100812 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
decreases expression |
EXP |
Dichlorvos results in decreased expression of CHRM3 protein |
CTD |
PMID:19100812 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:15733544 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:15733544 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
multiple interactions decreases activity |
ISO |
Dichlorvos inhibits the reaction [CP 55244 binds to CNR1 protein] Dichlorvos results in decreased activity of CNR1 protein |
CTD |
PMID:12243867 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases phosphorylation |
EXP |
Dichlorvos results in decreased phosphorylation of CREB1 protein |
CTD |
PMID:19100812 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
EXP |
Dichlorvos results in increased expression of CYBB mRNA; Dichlorvos results in increased expression of CYBB protein |
CTD |
PMID:21964614 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
EXP |
Dichlorvos affects the localization of CYCS protein mitoquinone inhibits the reaction [Dichlorvos affects the localization of CYCS protein] |
CTD |
PMID:17850875 PMID:21784090 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Dbh |
dopamine beta-hydroxylase |
increases activity multiple interactions |
EXP |
Dichlorvos results in increased activity of DBH protein Nimodipine inhibits the reaction [Dichlorvos results in increased activity of DBH protein] |
CTD |
PMID:12186780 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
affects response to substance |
ISO |
DLG2 gene SNP affects the susceptibility to Dichlorvos |
CTD |
PMID:25622337 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases activity multiple interactions |
EXP |
Dichlorvos results in decreased activity of DRD2 protein Nimodipine inhibits the reaction [Dichlorvos results in decreased activity of DRD2 protein] |
CTD |
PMID:12186780 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases activity |
ISO |
Dichlorvos results in decreased activity of ESR1 protein |
CTD |
PMID:22562034 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression |
ISO |
Dichlorvos results in decreased expression of FAS protein |
CTD |
PMID:15369847 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
Dichlorvos results in decreased expression of FASL protein |
CTD |
PMID:15369847 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gabrd |
gamma-aminobutyric acid type A receptor subunit delta |
decreases expression |
EXP |
Dichlorvos results in decreased expression of GABRD mRNA |
CTD |
PMID:19146868 |
|
NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:165,958,484...165,970,411
|
|
G |
Gck |
glucokinase |
decreases activity increases expression |
EXP |
Dichlorvos results in decreased activity of GCK protein Dichlorvos results in increased expression of GCK mRNA |
CTD |
PMID:16153661 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases expression multiple interactions decreases activity increases activity |
EXP |
Dichlorvos results in decreased expression of GSR protein [Hexachlorocyclohexane co-treated with Dichlorvos co-treated with Plant Extracts] results in decreased activity of GSR protein; [Hexachlorocyclohexane co-treated with Dichlorvos] results in decreased activity of GSR protein; Dichlorvos inhibits the reaction [sodium arsenite results in increased activity of GSR protein]; Plant Extracts inhibits the reaction [Dichlorvos results in decreased activity of GSR protein]; sodium arsenite inhibits the reaction [Dichlorvos results in increased activity of GSR protein] |
CTD |
PMID:18539328 PMID:20302853 PMID:22224058 PMID:22751200 PMID:25895260 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gys2 |
glycogen synthase 2 |
increases activity |
EXP |
Dichlorvos results in increased activity of GYS2 protein |
CTD |
PMID:222008 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
Gzma |
granzyme A |
decreases expression |
ISO |
Dichlorvos results in decreased expression of GZMA mRNA; Dichlorvos results in decreased expression of GZMA protein |
CTD |
PMID:16002202 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
Gzmb |
granzyme B |
decreases expression |
ISO |
Dichlorvos results in decreased expression of GZMB protein |
CTD |
PMID:18063463 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Gzmk |
granzyme K |
decreases expression |
ISO |
Dichlorvos results in decreased expression of GZMK protein |
CTD |
PMID:18063463 |
|
NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894
|
|
G |
Hdc |
histidine decarboxylase |
increases activity |
EXP |
Dichlorvos results in increased activity of HDC protein |
CTD |
PMID:119426 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hk1 |
hexokinase 1 |
decreases activity |
EXP |
Dichlorvos results in decreased activity of HK1 protein |
CTD |
PMID:10544956 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
ISO |
Dichlorvos results in decreased expression of HMOX1 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of HMOX1 protein] |
CTD |
PMID:26814074 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
decreases expression multiple interactions |
EXP |
Dichlorvos results in decreased expression of IFNG protein [Dichlorvos co-treated with cyfluthrin co-treated with Xylenes co-treated with Kerosene] affects the expression of IFNG protein |
CTD |
PMID:12838427 PMID:19145326 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
increases expression increases secretion |
EXP |
Dichlorvos results in increased expression of IL1B mRNA; Dichlorvos results in increased expression of IL1B protein Dichlorvos results in increased secretion of IL1B protein |
CTD |
PMID:21964614 PMID:22817663 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
decreases response to substance |
ISO |
Dichlorvos results in decreased susceptibility to IL2 protein |
CTD |
PMID:8349949 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
increases expression |
EXP |
Dichlorvos results in increased expression of IL6 mRNA; Dichlorvos results in increased expression of IL6 protein |
CTD |
PMID:21964614 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
INS1 protein inhibits the reaction [Dichlorvos results in increased abundance of Glucose] |
CTD |
PMID:222008 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression multiple interactions |
EXP |
Dichlorvos results in increased expression of ITGAM mRNA; Dichlorvos results in increased expression of ITGAM protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of ITGAM protein] |
CTD |
PMID:21964614 PMID:22817663 PMID:24369695 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
decreases activity multiple interactions |
ISO |
Dichlorvos results in decreased activity of LCAT protein Dichlorvos inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] |
CTD |
PMID:4847537 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lpl |
lipoprotein lipase |
decreases activity |
EXP |
Dichlorvos results in decreased activity of LPL protein |
CTD |
PMID:3196159 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Maoa |
monoamine oxidase A |
decreases activity |
EXP |
Dichlorvos results in decreased activity of MAOA protein |
CTD |
PMID:12018584 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
decreases activity |
EXP |
Dichlorvos results in decreased activity of MAOB protein |
CTD |
PMID:12018584 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions increases phosphorylation |
EXP |
Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein] |
CTD |
PMID:11282359 PMID:16635102 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
Dichlorvos results in increased expression of MGMT mRNA |
CTD |
PMID:21813463 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
affects expression decreases activity |
EXP ISO |
Dichlorvos affects the expression of NCEH1 protein modified form Dichlorvos results in decreased activity of NCEH1 protein |
CTD |
PMID:6245657 PMID:16978018 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression |
EXP |
Dichlorvos affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
EXP |
Dichlorvos results in decreased expression of NEFL mRNA |
CTD |
PMID:19146868 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity multiple interactions decreases expression |
ISO |
Dichlorvos results in increased activity of NFE2L2 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein] Dichlorvos results in decreased expression of NFE2L2 mRNA; Dichlorvos results in decreased expression of NFE2L2 protein |
CTD |
PMID:20143881 PMID:25891459 PMID:26814074 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
EXP |
Dichlorvos results in increased expression of NOS2 mRNA; Dichlorvos results in increased expression of NOS2 protein TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of NOS2 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of NOS2 protein] |
CTD |
PMID:22817663 PMID:24369695 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression multiple interactions |
ISO |
Dichlorvos results in decreased expression of NQO1 protein PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NQO1 protein] |
CTD |
PMID:26814074 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases activity multiple interactions increases cleavage |
EXP |
Dichlorvos results in increased activity of PARP1 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos results in increased activity of PARP1 protein] Dichlorvos results in increased cleavage of PARP1 protein |
CTD |
PMID:24231740 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
decreases activity |
ISO EXP |
Dichlorvos results in decreased activity of PNPLA6 protein |
CTD |
PMID:7713347 PMID:9268605 PMID:9586870 PMID:10776595 PMID:11282359 PMID:11705460 More...
|
|
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions increases secretion |
EXP |
Dichlorvos inhibits the reaction [POMC protein modified form results in increased chemical synthesis of Adrenal Cortex Hormones] Dichlorvos results in increased secretion of POMC protein modified form |
CTD |
PMID:2993719 PMID:6245657 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions decreases response to substance decreases expression decreases activity |
EXP ISO |
1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)but-2-ene inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; asoxime chloride inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; Obidoxime Chloride inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein]; Trimedoxime inhibits the reaction [Dichlorvos results in decreased activity of PON1 protein] PON1 protein results in decreased susceptibility to Dichlorvos PON1 protein inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of ACHE protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of HMOX1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NQO1 protein]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of PON1 mRNA]; PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of PON1 protein] Dichlorvos results in decreased expression of PON1 mRNA; Dichlorvos results in decreased expression of PON1 protein |
CTD |
PMID:20412842 PMID:25891459 PMID:26814074 PMID:29098328 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Prf1 |
perforin 1 |
decreases expression |
ISO |
Dichlorvos results in decreased expression of PRF1 mRNA; Dichlorvos results in decreased expression of PRF1 protein |
CTD |
PMID:16002202 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
multiple interactions increases expression |
EXP |
TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of PRKDC mRNA] Dichlorvos results in increased expression of PRKDC mRNA; Dichlorvos results in increased expression of PRKDC protein |
CTD |
PMID:24369695 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Pygb |
glycogen phosphorylase B |
increases activity |
EXP |
Dichlorvos results in increased activity of PYGB protein |
CTD |
PMID:10544956 |
|
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
|
|
G |
Pygl |
glycogen phosphorylase L |
increases activity |
EXP |
Dichlorvos results in increased activity of PYGL protein |
CTD |
PMID:222008 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Scarb2 |
scavenger receptor class B, member 2 |
multiple interactions |
EXP |
[Dichlorvos co-treated with Methylnitrosourea] results in increased expression of SCARB2 protein |
CTD |
PMID:37469457 |
|
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
multiple interactions |
EXP |
[Dichlorvos co-treated with cyfluthrin co-treated with Xylenes co-treated with Kerosene] results in increased expression of SCGB1A1 protein |
CTD |
PMID:12838427 |
|
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
|
|
G |
Snca |
synuclein alpha |
multiple interactions affects localization |
EXP |
coenzyme Q10 inhibits the reaction [Dichlorvos promotes the reaction [SNCA protein binds to SNCA protein]]; Dichlorvos promotes the reaction [SNCA protein binds to SNCA protein] Dichlorvos affects the localization of SNCA protein |
CTD |
PMID:21073741 PMID:21843543 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions decreases activity |
EXP |
[mitoquinone results in increased expression of SOD2 protein] which results in decreased susceptibility to Dichlorvos; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dichlorvos results in decreased activity of SOD2 protein] |
CTD |
PMID:17850875 PMID:21784090 PMID:24231740 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
EXP |
Dichlorvos results in increased expression of TAP1 mRNA |
CTD |
PMID:21813463 |
|
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions increases expression |
EXP |
[Atropine co-treated with Obidoxime Chloride co-treated with Diazepam] inhibits the reaction [Dichlorvos results in increased expression of TAT protein] |
CTD |
PMID:7761789 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tf |
transferrin |
affects binding |
ISO |
Dichlorvos binds to TF protein Dichlorvos binds to TRF protein |
CTD |
PMID:18930948 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Th |
tyrosine hydroxylase |
increases activity multiple interactions |
EXP |
Dichlorvos results in increased activity of TH protein Nimodipine inhibits the reaction [Dichlorvos results in increased activity of TH protein] |
CTD |
PMID:12186780 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
increases expression increases secretion |
EXP |
Dichlorvos results in increased expression of TNF mRNA; Dichlorvos results in increased expression of TNF protein Dichlorvos results in increased secretion of TNF protein |
CTD |
PMID:21964614 PMID:22817663 PMID:23053939 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression multiple interactions increases expression |
EXP |
Dichlorvos results in decreased expression of TP53 mRNA TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 mRNA]; TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of TP53 protein] Dichlorvos results in increased expression of TP53 mRNA; Dichlorvos results in increased expression of TP53 protein |
CTD |
PMID:23053939 PMID:24369695 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
increases phosphorylation |
EXP |
Dichlorvos results in increased phosphorylation of TUBB protein |
CTD |
PMID:11282359 PMID:16635102 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
decreases activity |
EXP |
Dichlorvos results in decreased activity of UGP2 protein |
CTD |
PMID:222008 |
|
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
|
|
G |
Xab2 |
XPA binding protein 2 |
affects response to substance |
ISO |
XAB2 gene SNP affects the susceptibility to Dichlorvos |
CTD |
PMID:22102698 |
|
NCBI chr12:1,667,672...1,679,702
Ensembl chr12:1,667,672...1,679,692
|
|